Brokerages Set Astera Labs, Inc. (NASDAQ:ALAB) PT at $233.75

Astera Labs, Inc. (NASDAQ:ALAB) has been assigned a consensus rating of “Moderate Buy” from the twenty-three research firms that are covering the firm, Marketbeat.com reports. Eleven investment analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $233.75.

Several analysts recently issued reports on the company. UBS Group assumed coverage on Astera Labs in a report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price objective for the company. Susquehanna increased their price objective on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. Roth Mkm reiterated a “buy” rating and set a $275.00 price objective on shares of Astera Labs in a report on Wednesday, May 6th. TD Cowen increased their price objective on Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a report on Wednesday, May 6th. Finally, Morgan Stanley increased their target price on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th.

Astera Labs Stock Down 11.4%

Shares of NASDAQ:ALAB opened at $317.06 on Friday. The company’s fifty day moving average is $212.95 and its two-hundred day moving average is $171.60. Astera Labs has a 12-month low of $84.78 and a 12-month high of $372.37. The company has a market cap of $54.35 billion, a P/E ratio of 214.23, a price-to-earnings-growth ratio of 4.74 and a beta of 3.95.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same period in the previous year, the business earned $0.33 EPS. The company’s revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities research analysts anticipate that Astera Labs will post 1.84 earnings per share for the current year.

Insider Activity

In other news, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total value of $19,692,630.00. Following the sale, the director directly owned 319,863 shares of the company’s stock, valued at approximately $34,420,457.43. This trade represents a 36.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the firm’s stock in a transaction dated Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the sale, the chief executive officer directly owned 4,079,322 shares in the company, valued at approximately $702,214,489.08. This represents a 7.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 2,311,256 shares of company stock valued at $477,341,446. Insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Several hedge funds and other institutional investors have recently made changes to their positions in ALAB. Glenmede Trust Co. NA grew its position in Astera Labs by 2.7% during the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after buying an additional 51 shares in the last quarter. Lido Advisors LLC grew its position in Astera Labs by 0.5% during the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock worth $2,046,000 after buying an additional 57 shares in the last quarter. Perigon Wealth Management LLC grew its position in Astera Labs by 6.2% during the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after buying an additional 73 shares in the last quarter. Clearstead Advisors LLC grew its position in Astera Labs by 13.6% during the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after buying an additional 76 shares in the last quarter. Finally, Sound Income Strategies LLC lifted its stake in Astera Labs by 9.2% during the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after purchasing an additional 76 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.